Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,032,146
-$3,713,999 QoQ
Shares Held
873,428
-0.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#278
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. PFE ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
This page
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,450 | $16,102,033 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,032,146 | 873,428 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,746,145 | 881,273 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,853,543 | 917,813 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $22,124,971 | 868,327 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $20,078,913 | 828,338 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,391,224 | 804,705 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,856,856 | 748,468 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $19,945,013 | 689,185 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $18,480,258 | 660,481 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $18,202,251 | 655,937 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $16,628,672 | 577,585 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,727,019 | 564,577 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,139,887 | 549,070 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,360,758 | 523,548 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $27,370,922 | 534,171 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $22,643,524 | 517,448 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $28,264,803 | 539,096 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $29,311,035 | 566,178 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $33,120,495 | 560,889 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $24,994,272 | 581,127 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $26,218,833 | 669,531 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $29,763,886 | 821,526 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $34,081,753 | 925,883 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $40,623,373 | 1,106,905 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $38,211,330 | 1,168,541 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $37,409,795 | 1,146,135 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||